Your Location：
Home >
Browse articles >
Xuebijing Injection Regulates Mitochondrial N-formyl Peptides/NLRP3 Inflammatory Pathway to Treat Severe Acute Pancreatitis in Rats
Updated：2022-03-07
Previous|Next

    • Xuebijing Injection Regulates Mitochondrial N-formyl Peptides/NLRP3 Inflammatory Pathway to Treat Severe Acute Pancreatitis in Rats

    • XIAO Yi , FENG Zhi-qiao , ZHANG Gui-xian , SHEN Hong-sheng , LI Wen-chang , LI Xia , GAO Rui-fang , LIU Hong-bin
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 28, Issue 7, Pages: 88-94(2022)

    • DOI： 10.13422/j.cnki.syfjx.20220738     

      CLC：

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • Figs( 3 ) Tabs( 4 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

147

Views

80

Downloads

3

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Protective Effect of Xuebijing on Lung Injury in Rats with Severe Acute Pancreatitis by Blocking FPRs/NLRP3 Inflammatory Pathway
Xuefu Zhuyutang Treats Coronary Heart Disease with Blood Stasis Syndrome in Rats via SIRT3 Signaling Pathway-mediated Regulation of Endothelial Function
Analysis on Theoretical Model and Pharmacological Mechanism of Staged Treatment of Severe Acute Pancreatitis with "Strengthening Healthy Qi to Eliminate Pathogenic Factors"
Xuefu Zhuyutang Ameliorates Metabolic-associated Fatty Liver Disease via AMPK Signaling Pathway
Regulatory Effect and Mechanisms of Liuhuang Zhike Prescription on Glycemic Control in db/db Mice via AMPK/Akt/GSK-3β Signaling Pathway

Related Author

ZHANG Guixian
LIU Dawei
LI Xia
LI Xijing
SHI Pengcheng
FENG Zhiqiao
CAI Jun
ZONG Wenhui

Related Institution

Health Commission of Heping District
Hunan Provincial Center for Drug Evaluation and Adverse Drug Reaction Monitoring
Hunan University of Chinese Medicine
Hospital of Chengdu University of Traditional Chinese Medicine
School of Integrated Chinese and Western Medicine， Hebei University of Chinese Medicine